295 related articles for article (PubMed ID: 26843367)
1. Going "social" to access experimental and potentially life-saving treatment: an assessment of the policy and online patient advocacy environment for expanded access.
Mackey TK; Schoenfeld VJ
BMC Med; 2016 Feb; 14():17. PubMed ID: 26843367
[TBL] [Abstract][Full Text] [Related]
2. (R)evolution: toward a new paradigm of policy and patient advocacy for expanded access to experimental treatments.
Hogan M
BMC Med; 2016 Feb; 14():39. PubMed ID: 26926908
[TBL] [Abstract][Full Text] [Related]
3. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
Rossen BR
Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of Publicly Available Expanded Access Policies.
Jung E; Zettler PJ; Kesselheim AS
Clin Pharmacol Ther; 2018 Nov; 104(5):1016-1021. PubMed ID: 29271014
[TBL] [Abstract][Full Text] [Related]
5. Should patients in need be given access to experimental drugs?
Caplan AL; Bateman-House A
Expert Opin Pharmacother; 2015 Jun; 16(9):1275-9. PubMed ID: 26001178
[TBL] [Abstract][Full Text] [Related]
6. Recommendations to Facilitate Expanded Access to Investigational Therapies for Seriously Ill Patients.
Jerome RN; Edwards TL; Boswell HC; Bernard GR; Harris PA; Pulley JM
Acad Med; 2016 Mar; 91(3):305-9. PubMed ID: 26445080
[TBL] [Abstract][Full Text] [Related]
7. Characterizing expanded access and compassionate use programs for experimental drugs.
Miller JE; Ross JS; Moch KI; Caplan AL
BMC Res Notes; 2017 Jul; 10(1):350. PubMed ID: 28754150
[TBL] [Abstract][Full Text] [Related]
8. Implementation of 21st Century Cures Act Expanded Access Policies Requirements.
Kang S; Chang S; Ross JS; Miller JE
Clin Pharmacol Ther; 2021 Dec; 110(6):1579-1584. PubMed ID: 34431083
[TBL] [Abstract][Full Text] [Related]
9. Access to Investigational Drugs: FDA Expanded Access Programs or "Right-to-Try" Legislation?
Holbein ME; Berglund JP; Weatherwax K; Gerber DE; Adamo JE
Clin Transl Sci; 2015 Oct; 8(5):526-32. PubMed ID: 25588691
[TBL] [Abstract][Full Text] [Related]
10. Right-to-try laws and individual patient "compassionate use" of experimental oncology medications: A call for improved provider-patient communication.
Hoerger M
Death Stud; 2016; 40(2):113-20. PubMed ID: 26313583
[TBL] [Abstract][Full Text] [Related]
11. Little to lose and no other options: Ethical issues in efforts to facilitate expanded access to investigational drugs.
Bunnik EM; Aarts N; van de Vathorst S
Health Policy; 2018 Sep; 122(9):977-983. PubMed ID: 29935731
[TBL] [Abstract][Full Text] [Related]
12. Federal Right to Try: Where Is It Going?
Folkers K; Chapman C; Redman B
Hastings Cent Rep; 2019 Mar; 49(2):26-36. PubMed ID: 30998281
[TBL] [Abstract][Full Text] [Related]
13. Regulating Rare Disease: Safely Facilitating Access to Orphan Drugs.
Bannister JB
Fordham Law Rev; 2018 Mar; 86(4):1889-921. PubMed ID: 29993206
[TBL] [Abstract][Full Text] [Related]
14. Expanded access to investigational drugs for treatment use. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2009 Aug; 74(155):40900-45. PubMed ID: 19691173
[TBL] [Abstract][Full Text] [Related]
15. Improving Expanded Access in the United States: The Role of the Institutional Review Board.
Folkers KM; Bateman-House A
Ther Innov Regul Sci; 2018 May; 52(3):285-293. PubMed ID: 29723059
[TBL] [Abstract][Full Text] [Related]
16. Right to experimental treatment: FDA new drug approval, constitutional rights, and the public's health.
Leonard EW
J Law Med Ethics; 2009; 37(2):269-79. PubMed ID: 19493072
[TBL] [Abstract][Full Text] [Related]
17. An analysis of common ethical justifications for compassionate use programs for experimental drugs.
Raus K
BMC Med Ethics; 2016 Oct; 17(1):60. PubMed ID: 27756370
[TBL] [Abstract][Full Text] [Related]
18. Patient advocacy organizations' information for patients on pre-approval access to investigational treatments.
Folkers KM; Leone S; Caplan A
BMC Res Notes; 2019 Oct; 12(1):706. PubMed ID: 31661023
[TBL] [Abstract][Full Text] [Related]
19. What do patients with unmet medical needs want? A qualitative study of patients' views and experiences with expanded access to unapproved, investigational treatments in the Netherlands.
Bunnik EM; Aarts N
BMC Med Ethics; 2019 Nov; 20(1):80. PubMed ID: 31706313
[TBL] [Abstract][Full Text] [Related]
20. Expanded access to investigational drugs in psychiatry: A systematic review.
Vermeulen SF; Polak TB; Bunnik EM
Psychiatry Res; 2023 Nov; 329():115554. PubMed ID: 37890403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
